This study was conducted to explore whether SNPs in CD295 (ID rs6700986) and ITLN1 (rs952804) confer risk for metabolic derangements of IR and/or diabetes mellitus (DM) in female BC patients in Egypt. The gene discussed is ITLN1; the disease is breast cancer.